Safety and Efficacy of Celecoxib Plus Nucleos(t)Ide Analogues on the Hepatitis B Surface Antigen of Virally Suppressed Subjects With Chronic Hepatitis B

Clinical trial NCT05256823 · UNKNOWN

Trial details

NCT number: NCT05256823
Sponsor: Lai Wei
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

To Evaluate the Safety and Efficacy of Celecoxib Plus Nucleos(t)Ide Analogues in Nucleos(t)Ide-treated Patients With Chronic Hepatitis B

Start date: 2022-02-24
Primary completion: 2023-11-30
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.